New York State Common Retirement Fund reduced its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 290,195 shares of the company’s stock after selling 31,547 shares during the period. New York State Common Retirement Fund owned 0.33% of Acadia Healthcare worth $14,330,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Columbia Partners L L C Investment Management purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $3,375,000. Thrivent Financial For Lutherans grew its holdings in Acadia Healthcare by 4.9% during the 2nd quarter. Thrivent Financial For Lutherans now owns 330,479 shares of the company’s stock valued at $16,319,000 after buying an additional 15,410 shares in the last quarter. ProShare Advisors LLC purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $340,000. Profund Advisors LLC purchased a new position in Acadia Healthcare during the 2nd quarter valued at about $482,000. Finally, Amalgamated Bank grew its holdings in Acadia Healthcare by 43.7% during the 2nd quarter. Amalgamated Bank now owns 15,128 shares of the company’s stock valued at $747,000 after buying an additional 4,597 shares in the last quarter.

Acadia Healthcare Company, Inc. (NASDAQ ACHC) opened at 46.94 on Thursday. The firm has a 50-day moving average price of $46.85 and a 200-day moving average price of $46.21. Acadia Healthcare Company, Inc. has a 12-month low of $32.54 and a 12-month high of $54.34. The company has a market cap of $4.12 billion, a P/E ratio of 515.82 and a beta of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. The firm’s revenue for the quarter was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.73 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current fiscal year.

In related news, Director Reeve B. Waud sold 1,240,000 shares of Acadia Healthcare stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $51.72, for a total transaction of $64,132,800.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Brent Turner sold 206,252 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total value of $10,454,913.88. Following the transaction, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold a total of 3,085,693 shares of company stock worth $157,729,099 in the last three months. Corporate insiders own 11.10% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “New York State Common Retirement Fund Has $14.33 Million Holdings in Acadia Healthcare Company, Inc. (ACHC)” was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.watchlistnews.com/new-york-state-common-retirement-fund-has-14-33-million-holdings-in-acadia-healthcare-company-inc-achc/1609488.html.

Several brokerages have recently commented on ACHC. Craig Hallum reaffirmed a “buy” rating and issued a $65.00 target price (up previously from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Deutsche Bank AG upped their target price on Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a research note on Monday, July 31st. UBS AG reaffirmed a “positive” rating and issued a $60.00 target price (up previously from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Zacks Investment Research lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Finally, BidaskClub lowered Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Acadia Healthcare presently has a consensus rating of “Buy” and an average price target of $56.90.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.